Status:
RECRUITING
The Therapy of Large Endometrioma
Lead Sponsor:
University Hospital, Lille
Conditions:
Endometrioma
Endometriosis Ovary
Eligibility:
FEMALE
18-40 years
Brief Summary
Endometrioma's prevalence is between 23 and 55%. It causes pelvic pain, decrease fertility and ovarian reserve. Currently, there's no recommendation about large endometrioma's treatment and there's n...
Eligibility Criteria
Inclusion
- Endometrioma size ≥ 6cm determined by MRI or ultrasonography
- Women with isolated endometrioma or other extraovarian endometriosis: peritoneal, infiltrating endometriotic lesions and adenomyosis.
- Cyst single or bilateral
Exclusion
- Cyst with radiographic or macroscopic in laparoscopy atypia
- Pregnancy
- Patient with contraindication to GnRH agonist (Enantone® 3,75 mg et Decapeptyl® 3 mg)
- Patient with contraindication to laparoscopy
- Patient with contraindication to general anesthesia
- Subject refusing to participate in the study
Key Trial Info
Start Date :
January 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04704115
Start Date
January 21 2021
End Date
December 1 2026
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Jeanne de Flandre Chu Lille
Lisle-sur-Tarn, France, 59037